Association of gene variants with incident myocardial infarction in the cardiovascular health study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 1, 2008, Pages 173-179

  Shiffman, Dov ^a   O'Meara, Ellen S ^b   Bare, Lance A ^a   Rowland, Charles M ^a   Louie, Judy Z ^a   Arellano, Andre R ^a   Lumley, Thomas ^b,c   Rice, Kenneth ^b   Iakoubova, Olga ^a   Luke, May M ^a   Young, Bradford A ^a   Malloy, Mary J ^d   Kane, John P ^d   Ellis, Stephen G ^e   Tracy, Russell P ^f   Devlin, James J ^a   Psaty, Bruce M ^c,g,h  

^a CELERA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF VERMONT   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h CENTER FOR HEALTH STUDIES   (United States)

Author keywords

Coronary disease; Genetics; Myocardial infarction; Polymorphisms

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LONGITUDINAL STUDIES; MALE; MYOCARDIAL INFARCTION; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; UNITED STATES;

EID: 37549058754     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.153981     Document Type: Article

References (25)

1. Zdravkovic S, Wienke A, Pedersen NL, Marenberg ME, Yashin AI, De Faire U. Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med. 2002;252:247-254.
2. Lusis AJ, Fogelman AM, Fonarow GC. Genetic basis of atherosclerosis: part I: new genes and pathways. Circulation. 2004;110:1868-1873.
3. Tell GS, Fried LP, Hermanson B, Manolio TA, Newman AB, Borhani NO. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol. 1993;3:358-366.
4. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, O'Leary DH, Psaty BM, Rautaharju P, Tracy RP, Weiler PG. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263-276.
5. Shiffman D, Ellis SG, Rowland CM, Malloy MJ, Luke MM, Iakoubova OA, Pullinger CR, Cassano J, Aouizerat BE, Fenwick RG, Reitz RE, Catanese JJ, Leong DU, Zellner C, Sninsky JJ, Topol EJ, Devlin JJ, Kane JP. Identification of four gene variants associated with myocardial infarction. Am J Hum Genet. 2005;77:596-605.
6. Shiffman D, Rowland CM, Louie JZ, Luke MM, Bare LA, Bolonick JI, Young BA, Catanese JJ, Stiggins CF, Pullinger CR, Topol EJ, Malloy MJ, Kane JP, Ellis SG, Devlin JJ. Gene variants of VAMP8 and HNRPUL1 are associated with early-onset myocardial infarction. Arterioscler Thromb Vasc Biol. 2006;26:1613-1618.
7. Luke MM, Kane JP, Liu DM, Rowland CM, Shiffman D, Cassano J, Catanese JJ, Pullinger CR, Leong DU, Arellano AR, Tong CH, Movsesyan I, Naya-Vigne J, Noordhof C, Feric NT, Malloy MJ, Topol EJ, Koschinsky ML, Devlin JJ, Stephen G Ellis SG. A Polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease. Arterioscler Thromb Vasc Biol. In press.
8. Iakoubova OA, Tong CH, Chokkalingam AP, Rowland CM, Kirchgessner TG, Louie JZ, Ploughman LM, Sabatine MS, Campos H, Catanese JJ, Leong DU, Young BA, Lew D, Tsuchihashi Z, Luke MM, Packard CJ, Zerba KE, Shaw PM, Shepherd J, Devlin JJ, Sacks FM. Asp92Asn polymorphism in the myeloid IgA Fc receptor is associated with myocardial infarction in two disparate populations: CARE and WOSCOPS. Arterioscler Thromb Vasc Biol. 2006;26:2763-2768.
9. Iakoubova OA, Tong CH, Rowland CM, Kirchgessner TG, Young BA, Arellano AR, Shiffman D, Sabatine MS, Campos H, Packard CJ, Pfeffer MA, White TJ, Braunwald E, Shepherd J, Devlin JJ, Sacks FM, MD. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in two prospective studies: the Cholesterol and Recurrent Events Study (CARE) and the West of Scotland Coronary Prevention Study (WOSCOPS). J Amer Coll Cardiol. 2007;27:2030-2036.
10. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP. Laboratory methods and quality control in the Cardiovascular Health Study. Clin Chem. 1995;41:264-270.
11. Psaty BM, Kuller LH, Bild D, Burke GL, Kittner SJ, Mittelmark M, Price TR, Rautaharju PM, Robbins J. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol. 1995;5:270-277.
12. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
13. Ives DG, Fitzpatrick AL, Bild DE, Psaty BM, Kuller LH, Crowley PM, Cruise RG, Theroux S. Surveillance and ascertainment of cardiovascular events: the Cardiovascular Health Study. Ann Epidemiol. 1995;5:278-285.
14. Cleves MA. Hardy-Weinberg Equilibrium Tests and Allele Frequency Estimation. STATA Technical Bulletin. No. 48, March 1999, 34-37. URL http://www.biostat-resources.com/stata/.
15. StataCorp. Stata Statistical Software: Release 9. College Station, TX: StataCorp LP, 2005.
16. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289-300.
17. R Development Core Team. R: A language and environment for statistical computing, reference index version 2.3.0. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org, 2005.
18. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96:434-442.
19. Morrison AC, Bare LA, Chambless LE, Ellis SG, Malloy MJ, Kane JP, Pankow JS, Devlin JJ, Willerson JT, Boerwinkle E. Coronary heart disease risk prediction using a genetic risk score: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 2007;166:28-35.
20. Bare LA, Morrison AC, Rowland CM, Shiffman D, Luke MM, Iakoubova OA, Kane JP, Malloy MJ, Ellis SG, Pankow JS, Willerson JT, Devlin JJ, Boerwinkle E. Five common gene variants identify elevated genetic risk for coronary heart disease. Genet Med. 2007;9:682-689.
21. The International HapMap Consortium. A Haplotype Map of the Human Genome. Nature. 2005;437:1299-1320.
22. Berg K, Dahlen G, Frick MH. Lp(a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease. Clin Genet. 1974;6:230-235.
23. Berg K. Lp(a) lipoprotein: an overview. Chem Phys Lipids. 1994;67-68:9-16.
24. Polgar J, Chung SH, Reed GL. Vesicle-associated membrane protein 3 (VAMP-3) and VAMP-8 are present in human platelets and are required for granule secretion. Blood. 2002;100:1081-1083.
25. Duffy VB. Associations between oral sensation, dietary behaviors and risk of cardiovascular disease (CVD). Appetite. 2004;43:5-9.